Senior Research Associate, Analytical Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Janux Therapeutics · 11 hours ago

Senior Research Associate, Analytical Development

Janux Therapeutics is seeking a Senior Research Associate to support the development of next-generation immune oncology drugs. The role involves designing and executing experiments, performing sample analysis, and effectively communicating results to advance novel research molecules toward clinical development.

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Responsibilities

Develop and perform HPLC and UPLC assays with minimal supervision including SEC, HIC, IEX, and RP
Develop and perform iCIEF and CE-SDS assays
Develop and perform ELISAs
Perform DLS/SLS analysis using an UNcle instrument and generate datasets that will be used for formulation development studies
Perform subvisible particulate matter analysis by HIAC
Perform formulation development studies and execute clinical in-use stability studies, transfer formulation knowledge internally
Design, conduct, analyze, interpret, and report laboratory experiments; summarize results for meetings and regulatory filings
Write and manage SOP’s and test methods, train colleagues and facilitate method transfer to partners and CDMOs
Manage and maintain required reagents, laboratory environment, and equipment needed to carry out assignments
Draft development reports, method qualification protocols, and method qualification reports
Prepare presentations for team meetings
Work closely with team leaders to complete highest priority work to reach goals and milestones
Other duties as assigned

Qualification

HPLCUPLCELISAICIEFCE-SDSDLS/SLSSOP writingComputer skillsCommunication skillsProblem-solvingTeam-orientedOrganizational skills

Required

Bachelor's degree in related scientific discipline with 4-6 years of relevant industry experience or Master's degree with 3-5 years of relevant industry experience required
Strong benchtop skills, experience with analysis of protein biologics and peptides
Proficient with the development of HPLC and UPLC assays; at least 3 years of experience is required
Experience developing and performing ELISAs
Knowledge and familiarity in employing various analytical techniques, to include but not be limited to: CE-SDS, iCIEF
Proven experience with writing and maintaining SOPs, ability to train others and to transfer methods to external partners
Ability to perform routine testing and to follow SOPs in a highly accurate and reproducible manner
Desire and ability to learn new technologies, thinking outside the box, and exploring new approaches to innovate
Training on project specific assays and ability to train others
Ability to work independently, anticipate, and solve problems in a proactive fashion
Excellent computer skills, proficiency with Microsoft Excel and PowerPoint required
Strong oral and written communication skills a must

Preferred

SEC, RP, HIC, and IEX experience is desired
Experience with DLS/SLS (UNcle), HIAC, HIC and CE-SDS ELISA (Simple Western) blotting or similar technology preferred
Experience with formulation development with focus on antibodies or bispecifics is highly desired

Benefits

Annual bonus program
Incentive stock option plan
401k plan with flat non-elective employer contribution
Comprehensive medical insurance with 90-100% employer-paid premiums
Dental and vision insurance
HSA, FSA, and supplemental insurance plans (life, disability, accident, critical illness, hospital indemnity)
Unlimited PTO
Generous holiday schedule; includes summer and winter company shutdown
Relocation assistance

Company

Janux Therapeutics

twittertwitter
company-logo
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Funding

Current Stage
Public Company
Total Funding
$898.94M
Key Investors
RA Capital ManagementAvalon Ventures
2024-12-03Post Ipo Equity· $350M
2024-02-29Post Ipo Equity· $296.5M
2023-07-17Post Ipo Equity· $60M

Leadership Team

leader-logo
David Campbell
President, CEO & Director (Founder)
linkedin
leader-logo
Byron Robinson
Chief Strategy Officer
linkedin
Company data provided by crunchbase